Discover key insights from Collegium Pharmaceutical's Q1 2025 earnings call: 23% revenue growth, Jornay PM's market success, sales force expansion & ...

Rigel Pharmaceuticals reports strong Q1 2025 growth, with revenue up 68% YoY. Learn about their $200M+ guidance, robust pipeline, and market strategy.

Biopharma company Jazz Pharmaceuticals (NASDAQ:JAZZ) in Q1 CY2025, with sales flat year on year at $897.8 million. On the ...

Once a leading marijuana stock, the Canadian cannabis company has pivoted to craft beer and is trying to prevent being ...

President Trump's MFN proposal will create many adverse consequences including reduced access to medicines, diminished drug ...

The British pharmaceutical giant said Wednesday that its first-quarter sales rose to 7.52 billion pounds ($10.08 billion) ...

He also said much of the gain in non-core items could be attributed to increases in food and pharmaceutical sales. Shelly Kaushik, a senior economist and vice-president of economics at BMO Economics, ...

MSD is also bracing for a $200m hit due to tariffs as it accelerates US manufacturing and shifts its global supply strategy.

Industry insiders believe the measure poses a serious risk to the pharmaceutical sector, potentially exceeding concerns over looming tariffs on drug imports. All the news that moves the needle in ...

The groups warn that tariffs would increase vehicle prices, lower sales and disrupt the supply chain. Trump previously indicated he might modify the tariffs to give automakers more time.

In the fast-paced pharmaceutical industry, sales teams face increasing pressure to meet sales targets, engage healthcare professionals effectively, and stay ahead of constant product innovations. Yet, ...